West Pharmaceutical Services Inc 1WST
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €330.60
- Day Range
- €337.80–337.80
- 52-Week Range
- €212.30–337.80
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 70.38M
- Market Cap
- $23.20B
- Volume/Avg
- 3 / 2
Key Statistics
- Price/Earnings (Normalized)
- 44.88
- Price/Sales
- 8.28
- Dividend Yield (Trailing)
- 0.23%
- Dividend Yield (Forward)
- 0.23%
- Dividend Payment Schedule
- Feb, May, Aug, Nov
- Total Yield
- 1.94%
Company Profile
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 10,800
- Website
- https://www.westpharma.com
Competitors
Valuation
|
Metric
|
1WST
|
BDX
|
PODD
|
|---|---|---|---|
Price/Earnings (Normalized) | 44.88 | 14.13 | 23.05 |
Price/Book Value | 8.79 | 2.05 | 6.60 |
Price/Sales | 8.28 | 2.59 | 3.17 |
Price/Cash Flow | 35.92 | 13.87 | 15.67 |
Price/Earnings
1WST
BDX
PODD
Financial Strength
|
Metric
|
1WST
|
BDX
|
PODD
|
|---|---|---|---|
Quick Ratio | 1.79 | 0.36 | 1.51 |
Current Ratio | 2.82 | 0.94 | 2.48 |
Interest Coverage | 150.98 | 3.53 | 9.04 |
Quick Ratio
1WST
BDX
PODD
Profitability
|
Metric
|
1WST
|
BDX
|
PODD
|
|---|---|---|---|
Return on Assets (Normalized) | 14.96% | 4.97% | 13.00% |
Return on Equity (Normalized) | 20.28% | 10.63% | 29.07% |
Return on Invested Capital (Normalized) | 18.06% | 7.26% | 17.78% |
Return on Assets
1WST
BDX
PODD
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|zH#S>@<v | LOCK|Yz | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|?QQ | LOCK|Z<s<? | $50B | |||
| ResMed Inc
RMD
| LOCK|>b^CL!j | LOCK|!CSY | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|!BJtp>g | LOCK|MGFX | $32B | |||
| Alcon Inc
ALC
| LOCK|pD#X$< | LOCK|@$nl | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|dk&Tm>k^ | LOCK|># | $26B | |||
| Solventum Corp
SOLV
| LOCK|&@VY!@ | LOCK|mTx | $15B | |||
| Baxter International Inc
BAX
| LOCK|Wrl | LOCK|gS!M | $13B | |||
| Repligen Corp
RGEN
| LOCK|>fwZPX<b | LOCK|?%xH | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|S%GT&! | LOCK|%N<>@ | $10B |
United States